The epidemiology of dengue outbreaks in 2016 and 2017 in Ouagadougou, Burkina Faso
Justin Im,
Ruchita Balasubramanian,
Moussa Ouedraogo,
Lady Rosny Wandji Nana,
Ondari D. Mogeni,
Hyon Jin Jeon,
Tayma van Pomeren,
Andrea Haselbeck,
Jacqueline Kyungah Lim,
Kristi Prifti,
Stephen Baker,
Christian G. Meyer,
Jerome H. Kim,
John D. Clemens,
Florian Marks,
Abdramane Bassiahi Soura
Affiliations
Justin Im
International Vaccine Institute, Seoul, Republic of Korea
Ruchita Balasubramanian
International Vaccine Institute, Seoul, Republic of Korea; Princeton University, Princeton, NJ, USA
Moussa Ouedraogo
Laboratorie d'Analyses Medicales, Centre Médical avec Antenne chirurgicale Protestant Schiphra, Ouagadougou, Burkina Faso
Lady Rosny Wandji Nana
Institut Supérieur des Sciences de la Population, Université de Ouagadougou, Ouagadougou, Burkina Faso
Ondari D. Mogeni
International Vaccine Institute, Seoul, Republic of Korea
Hyon Jin Jeon
International Vaccine Institute, Seoul, Republic of Korea; The Department of Medicine, University of Cambridge, Cambridge, United Kingdom
Tayma van Pomeren
International Vaccine Institute, Seoul, Republic of Korea; Institut Supérieur des Sciences de la Population, Université de Ouagadougou, Ouagadougou, Burkina Faso
Andrea Haselbeck
International Vaccine Institute, Seoul, Republic of Korea
Jacqueline Kyungah Lim
International Vaccine Institute, Seoul, Republic of Korea
Kristi Prifti
International Vaccine Institute, Seoul, Republic of Korea
Stephen Baker
The Department of Medicine, University of Cambridge, Cambridge, United Kingdom
Christian G. Meyer
Duy Tan University, Da Nang, Viet Nam; Institute for Tropical Medicine, Eberhard Karls University, Tübingen, Germany
Jerome H. Kim
International Vaccine Institute, Seoul, Republic of Korea
John D. Clemens
International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh; University of California, Fielding School of Public Health, Los Angeles, USA
Florian Marks
International Vaccine Institute, Seoul, Republic of Korea; The Department of Medicine, University of Cambridge, Cambridge, United Kingdom; Corresponding author.
Abdramane Bassiahi Soura
Institut Supérieur des Sciences de la Population, Université de Ouagadougou, Ouagadougou, Burkina Faso
Background: Dengue is prevalent in as many as 128 countries with more than 100 million clinical episodes reported annually and four billion people estimated to be at risk. While dengue fever is systematically diagnosed in large parts of Asia and South America, the disease burden in Africa is less well investigated. This report describes two consecutive dengue outbreaks in Ouagadougou, Burkina Faso in 2016 and 2017. Methods: Blood samples of febrile patients received at Schiphra laboratory in Ouagadougou, Burkina Faso, were screened for dengue infection using SD Bioline Dengue Duo rapid diagnostic test kits (Standard Diagnostics, Suwon, Republic of Korea). Results: A total of 1,397 and 1,882 cases were reported by a single laboratory in 2016 and 2017, respectively. Most cases were at least 15 years of age and the results corroborated reports from WHO indicating the circulation of three dengue virus serotypes in Burkina Faso. Conclusion: This study complements data from other, simultaneously conducted surveillance efforts, and indicates that the dengue disease burden might be underestimated in sub-Saharan African nations. Dengue surveillance should be enhanced in African settings to determine the burden more accurately, and accelerated efforts towards a dengue vaccine should be put in place.
